i2S SA Stocks

6.5Last Updated 13.04.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

€ 12.71M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
6.5
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Decent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

i2S SA provides image capture and processing solution in France. The company offers heritage digitization solutions, including small book, large book, and V shape book scanners; range of software solutions, such as LIMB Capture, a solution for digitization of projects; LIMB processing, a software for processing, enhancing, and converting cultural heritage into digital cultural heritage; LIMB Gallery, a digital library; and LIBM Maestro that supervises digitization of projects to libraries, archives, museums, service providers, and universities. It also provides health wellness solutions comprising in vitro diagnostic medical devices; connected portable tools; and e-health software solutions, as well as Irisolution platform. In addition, the company designs and develops custom industrial cameras; and inspection and data processing systems; as well as offers standard vision components. i2S SA was founded in 1979 and is headquartered in Pessac, France.

Company Valuation

Slightly overvalued
3/7

Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks